Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Int J Mol Sci ; 24(8)2023 Apr 17.
Article in English | MEDLINE | ID: mdl-37108548

ABSTRACT

CCL2 is an inflammatory cytokine that regulates macrophage activity and is implicated in increased mammographic density and early breast tumorigenesis. The role of CCL2 in mediating stromal interactions that contribute to breast tumorigenesis has yet to be fully elucidated. THP-1-derived macrophages and mammary fibroblasts were co-cultured for 72 h. Fibroblasts and macrophages were analysed for phenotype, expression of inflammatory and ECM-regulatory genes and collagen production. Mice overexpressing CCL2 in the mammary glands were analysed for global gene expression by RNAseq at 12 weeks of age. These mice were cross-bred with PyMT mammary tumour mice to examine the role of CCL2 in tumorigenesis. The co-culture of macrophages with fibroblasts resulted in macrophage polarization towards an M2 phenotype, and upregulated expression of CCL2 and other genes associated with inflammation and ECM remodelling. CCL2 increased the production of insoluble collagen by fibroblasts. A global gene expression analysis of CCL2 overexpressing mice revealed that CCL2 upregulates cancer-associated gene pathways and downregulates fatty acid metabolism gene pathways. In the PyMT mammary tumour model, CCL2 overexpressing mice exhibited increased macrophage infiltration and early tumorigenesis. Interactions between macrophages and fibroblasts regulated by CCL2 can promote an environment that may increase breast cancer risk, leading to enhanced early tumorigenesis.


Subject(s)
Chemokine CCL2 , Neoplasms , Mice , Animals , Chemokine CCL2/genetics , Chemokine CCL2/metabolism , Macrophages/metabolism , Collagen/metabolism , Neoplasms/metabolism , Carcinogenesis/metabolism
2.
Proc Natl Acad Sci U S A ; 108(30): 12437-42, 2011 Jul 26.
Article in English | MEDLINE | ID: mdl-21746930

ABSTRACT

Mutations in the gene encoding the transcription factor autoimmune regulator (AIRE) are responsible for autoimmune polyendocrinopathy candidiasis ectodermal dystrophy syndrome. AIRE directs expression of tissue-restricted antigens in the thymic medulla and in lymph node stromal cells and thereby substantially contributes to induction of immunological tolerance to self-antigens. Data from experimental mouse models showed that AIRE deficiency leads to impaired deletion of autospecific T-cell precursors. However, a potential role for AIRE in the function of regulatory T-cell populations, which are known to play a central role in prevention of immunopathology, has remained elusive. Regulatory T cells of CD8(+)CD28(low) phenotype efficiently control immune responses in experimental autoimmune and colitis models in mice. Here we show that CD8(+)CD28(low) regulatory T lymphocytes from AIRE-deficient mice are transcriptionally and phenotypically normal and exert efficient suppression of in vitro immune responses, but completely fail to prevent experimental colitis in vivo. Our data therefore demonstrate that AIRE plays an important role in the in vivo function of a naturally occurring regulatory T-cell population.


Subject(s)
Colitis/immunology , T-Lymphocytes, Regulatory/immunology , Transcription Factors/deficiency , Animals , CD28 Antigens/metabolism , CD8 Antigens/metabolism , Colitis/genetics , Colitis/pathology , Colitis/prevention & control , Disease Models, Animal , Gene Expression Profiling , In Vitro Techniques , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Knockout , Mutation , Phenotype , Polyendocrinopathies, Autoimmune/genetics , Polyendocrinopathies, Autoimmune/immunology , Receptors, Antigen, T-Cell/metabolism , Self Tolerance , T-Lymphocyte Subsets/immunology , Transcription Factors/genetics , Transcription Factors/immunology , AIRE Protein
3.
Mol Carcinog ; 52(6): 459-74, 2013 Jun.
Article in English | MEDLINE | ID: mdl-22308110

ABSTRACT

Diet-derived butyrate, a histone deacetylase inhibitor (HDI), decreases proliferation and increases apoptosis in colorectal cancer (CRC) cells via epigenetic changes in gene expression. Other HDIs such as suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA) have similar effects. This study examined the role of microRNAs (miRNAs) in mediating the chemo-protective effects of HDIs, and explored functions of the oncogenic miR-17-92 cluster. The dysregulated miRNA expression observed in HT29 and HCT116 CRC cells could be epigenetically altered by butyrate, SAHA and TSA. These HDIs decreased expression of miR-17-92 cluster miRNAs (P < 0.05), with a corresponding increase in miR-17-92 target genes, including PTEN, BCL2L11, and CDKN1A (P < 0.05). The decrease in miR-17-92 expression may be partly responsible for the anti-proliferative effects of HDIs, with introduction of miR-17-92 cluster miRNA mimics reversing this effect and decreasing levels of PTEN, BCL2L11, and CDKN1A (P < 0.05). The growth effects of HDIs may be mediated by changes in miRNA activity, with down-regulation of the miR-17-92 cluster a plausible mechanism to explain some of the chemo-protective effects of HDIs. Of the miR-17-92 cluster miRNAs, miR-19a and miR-19b were primarily responsible for promoting proliferation, while miR-18a acted in opposition to other cluster members to decrease growth. NEDD9 and CDK19 were identified as novel miR-18a targets and were shown to be pro-proliferative genes, with RNA interference of their transcripts decreasing proliferation in CRC cells. This is the first study to identify competing roles for miR-17-92 cluster members, in the context of HDI-induced changes in CRC cells.


Subject(s)
Adenocarcinoma/drug therapy , Butyric Acid/pharmacology , Colorectal Neoplasms/drug therapy , Histone Deacetylase Inhibitors/pharmacology , Hydroxamic Acids/pharmacology , MicroRNAs/genetics , Adaptor Proteins, Signal Transducing/genetics , Adenocarcinoma/genetics , Apoptosis Regulatory Proteins/genetics , Bcl-2-Like Protein 11 , Colorectal Neoplasms/genetics , Cyclin-Dependent Kinase Inhibitor p21/genetics , Down-Regulation/drug effects , Gene Expression Regulation, Neoplastic/drug effects , HCT116 Cells , HT29 Cells , Humans , Membrane Proteins/genetics , PTEN Phosphohydrolase/genetics , Phosphoproteins/genetics , Proto-Oncogene Proteins/genetics , RNA, Long Noncoding , RNA, Messenger/genetics , Transfection , Vorinostat
4.
Infect Immun ; 80(9): 3268-78, 2012 Sep.
Article in English | MEDLINE | ID: mdl-22778095

ABSTRACT

Streptococcus pneumoniae (the pneumococcus) continues to be responsible for a high level of global morbidity and mortality resulting from pneumonia, bacteremia, meningitis, and otitis media. Here we have used a novel technique involving niche-specific, genome-wide in vivo transcriptomic analyses to identify genes upregulated in distinct niches during pathogenesis after intranasal infection of mice with serotype 4 or 6A pneumococci. The analyses yielded 28 common, significantly upregulated genes in the lungs relative to those in the nasopharynx and 25 significantly upregulated genes in the blood relative to those in the lungs in both strains, some of which were previously unrecognized. The role of five upregulated genes from either the lungs or the blood in pneumococcal pathogenesis and virulence was then evaluated by targeted mutagenesis. One of the mutants (ΔmalX) was significantly attenuated for virulence in the lungs, two (ΔaliA and ΔilvH) were significantly attenuated for virulence in the blood relative to the wild type, and two others (ΔcbiO and ΔpiuA) were completely avirulent in a mouse intranasal challenge model. We also show that the products of aliA, malX, and piuA are promising candidates for incorporation into multicomponent protein-based pneumococcal vaccines currently under development. Importantly, we suggest that this new approach is a viable complement to existing strategies for the discovery of genes critical to the distinct stages of invasive pneumococcal disease and potentially has broad application for novel protein antigen discovery in other pathogens such as S. pyogenes, Haemophilus influenzae type b, and Neisseria meningitidis.


Subject(s)
Gene Expression Profiling , Pneumococcal Infections/microbiology , Pneumococcal Infections/pathology , Streptococcus pneumoniae/genetics , Streptococcus pneumoniae/pathogenicity , Virulence Factors/genetics , Virulence Factors/metabolism , Animals , Bacteremia/microbiology , Bacteremia/pathology , Mice , Nasopharynx/microbiology , Pneumonia, Bacterial/microbiology , Pneumonia, Bacterial/pathology
5.
Immunol Cell Biol ; 90(2): 168-77, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21445089

ABSTRACT

Vitamin D (vit D) status has been linked to the occurrence and severity of auto-immune and inflammatory diseases. This study evaluates the effects of vit D status on adoptive transfer of adjuvant-induced arthritis (ATA). Rats maintained on diets replete or deficient in vit D3 received arthritogenic thoracic duct cells and were monitored for severity of arthritis. CD45(+) cells obtained by collagenase digestion of hind-paw synovium-rich tissues (SRTs) were analysed to observe the effects of dietary vit D3 on the inflammatory process. Arthritis was more severe in vitamin D-deficient (vit-D(-)) rats compared with vitamin D-replete (vit-D(+)) rats. Resolution was delayed in vit-D(-) rats compared with vit-D(+) rats, or rats fed standard chow. During the acute phase of ATA, numbers of CD45(+) cells were significantly increased in the SRTs of vit-D(-) rats compared with vit-D(+) rats. This increase involved T-cells, polymorphonuclear leukocytes, macrophages, dendritic cells (DCs) and MHC II(hi) cells that resemble activated monocytes. A major difference between the dietary groups was that most DCs at the peak of inflammation in vit-D(-) rats were CD4(-), whereas in convalescent vit-D(+) rats most expressed CD4. Multiple categories of genes expressed by DCs differed between deficient and replete rats, with deficiency being associated with relative upregulation of certain pro-inflammatory genes and replete status being associated with upregulation of genes associated with resolution of inflammation. The findings indicate that ATA is more severe and prolonged in vit-D deficiency, that vit-D deficiency promotes accumulation of CD4(-) DCs in synovium during ATA and that a gene-expression profile is likely to contribute to the observed increased severity and duration of arthritis.


Subject(s)
Arthritis, Experimental/immunology , Arthritis/immunology , Vitamin D Deficiency/immunology , Vitamin D/pharmacology , Adoptive Transfer , Animals , CD4 Antigens/metabolism , Dendritic Cells/immunology , Female , Leukocyte Common Antigens/metabolism , Macrophages/immunology , Neutrophils/immunology , Rats , Synovial Membrane/chemistry , Synovial Membrane/cytology , T-Lymphocytes/immunology , Vitamin D/administration & dosage
6.
Physiol Genomics ; 43(10): 611-20, 2011 May 01.
Article in English | MEDLINE | ID: mdl-21245416

ABSTRACT

Pluripotent embryonic stem cells (ESC) have the potential to differentiate into any cell type of the three germ layers. Differentiation processes depend on genetic and epigenetic factors. The guidance of cell fate determination by microRNAs (miRs) seems important for embryonic development and cell lineage decisions. MiRs are short, single-stranded, noncoding RNA molecules that regulate through posttranscriptional modulation, a subset of target genes involved in cell differentiation and specific cell function. We have used microarray profiling of miRs in the mouse embryonic stem cell line CGR8. Comparison of the miR profiles of undifferentiated stem cells with mesodermal progenitors cells (day 5), preadipocytes (day 10), and adipocytes (day 21) showed that the expression level of 129 miRs changed (twofold) during adipogenic differentiation. We identified 10 clusters of differentially expressed miRs, which contain putative markers and regulators of mesodermal differentiation and cell fate determination into adipocytes. Notably, the adipocyte-specific miRs 143 and 103 were upregulated from day 10 onward. We have therefore demonstrated and characterized the dynamic profile of miR expression during murine adipogenic differentiation in vitro, including the initial differentiation from ESC via mesenchymal progenitors up to adipocytes. Our findings and experimental approach provide a suitable system to directly interrogate the role of miRs during adipogenic differentiation of embryonic stem cells.


Subject(s)
Adipogenesis/genetics , Embryonic Stem Cells/metabolism , MicroRNAs/genetics , Adipocytes/drug effects , Adipocytes/metabolism , Adipocytes/physiology , Adipogenesis/drug effects , Adipogenesis/physiology , Animals , Cell Differentiation/drug effects , Cell Differentiation/genetics , Cells, Cultured , Cluster Analysis , Embryonic Stem Cells/drug effects , Embryonic Stem Cells/physiology , Gene Expression , Gene Expression Profiling , Glucose/pharmacology , Mice , MicroRNAs/metabolism , Microarray Analysis
7.
Histochem Cell Biol ; 135(1): 37-45, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21170745

ABSTRACT

Damage to sensory neurons induces neural repair, regrowth and hyperexcitability. The regulation of such responses to injury must be organized in some way by the neurons. Regulation can occur at the post-transcriptional level via microRNAs (miRNAs). miRNAs are small non-coding RNAs that influence the stability or translation of mRNAs and thereby regulate gene expression. Although nociceptive neurons show transcriptional and post-transcriptional regulatory mechanisms at many levels, miRNAs have not yet been systematically investigated in these neurons. Based on our preliminary array data we investigated the presence of miR-1 in dorsal root ganglion (DRG) neurons of mice and humans. We detected miR-1 in total RNA from human and mouse DRG and localised miR-1 in human and murine sensory neurons in situ. In Situ Hybridization detected miR-1 expression by nearly all DRG neurons. In vitro studies of enriched sensory neuron subpopulations from mouse DRG showed higher miR-1 expression levels in I-B4 negative neurons compared with I-B4 positive cells. Culturing of primary sensory neurons reduced the relative miR-1 expression levels independent of the presence or absence of laminin on the culture substrate. Transfection with a miR-1 mimic induced a massive increase in neuronal miR-1 associated with attenuated neurite outgrowth. This first description of miR-1 in sensory neurons including nociceptors suggests that miR-1 has a role in modulating neurite outgrowth.


Subject(s)
Ganglia, Spinal/metabolism , Gene Expression Regulation , MicroRNAs/metabolism , Neurons/metabolism , Animals , Cells, Cultured , Computer Simulation , Humans , Immunohistochemistry , Mice , MicroRNAs/genetics , Microarray Analysis , Protein Processing, Post-Translational , Reverse Transcriptase Polymerase Chain Reaction
8.
J Bacteriol ; 192(17): 4489-97, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20601473

ABSTRACT

The importance of Mn(2+) for pneumococcal physiology and virulence has been studied extensively. However, the specific cellular role(s) for which Mn(2+) is required are yet to be fully elucidated. Here, we analyzed the effect of Mn(2+) limitation on the transcriptome and proteome of Streptococcus pneumoniae D39. This was carried out by comparing a deletion mutant lacking the solute binding protein of the high-affinity Mn(2+) transporter, pneumococcal surface antigen A (PsaA), with its isogenic wild-type counterpart. We provide clear evidence for the Mn(2+)-dependent regulation of the expression of oxidative-stress-response enzymes SpxB and Mn(2+)-SodA and virulence-associated genes pcpA and prtA. We also demonstrate the upregulation of at least one oxidative- and nitrosative-stress-response gene cluster, comprising adhC, nmlR, and czcD, in response to Mn(2+) stress. A significant increase in 6-phosphogluconate dehydrogenase activity in the psaA mutant grown under Mn(2+)-replete conditions and upregulation of an oligopeptide ABC permease (AppDCBA) were also observed. Together, the results of transcriptomic and proteomic analyses provided evidence for Mn(2+) having a central role in activating or stimulating enzymes involved in central carbon and general metabolism. Our results also highlight the importance of high-affinity Mn(2+) transport by PsaA in pneumococcal competence, physiology, and metabolism and elucidate mechanisms underlying the response to Mn(2+) stress.


Subject(s)
Adhesins, Bacterial/metabolism , Gene Expression Regulation, Bacterial , Heat-Shock Response , Lipoproteins/metabolism , Manganese/metabolism , Streptococcus pneumoniae/metabolism , Streptococcus pneumoniae/physiology , Adhesins, Bacterial/genetics , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Culture Media , Electrophoresis, Gel, Two-Dimensional , Gene Deletion , Gene Expression Profiling , Gene Expression Regulation, Bacterial/drug effects , Lipoproteins/genetics , Manganese/pharmacology , Oligonucleotide Array Sequence Analysis , Oxidative Stress , Proteome , Streptococcus pneumoniae/genetics , Streptococcus pneumoniae/growth & development
9.
Gastroenterology ; 136(3): 967-77, 2009 Mar.
Article in English | MEDLINE | ID: mdl-19121317

ABSTRACT

BACKGROUND & AIMS: Gastric cancer is the second most common cause of cancer-related mortality worldwide, mainly as a result of late-stage detection. Interleukin (IL)-11 is a multifunctional cytokine reported to be up-regulated in human gastric cancer. METHODS: We investigated the importance of IL-11 in gastric cancer progression by examining its role in a variety of mouse gastric tumor models, as well as in nonneoplastic and tumor tissues taken from gastric cancer patients. We then determined the transcriptional and translational outcomes of IL-11 overexpression in normal gastric mucosa and identified a novel gene signature important early in the progression toward gastric tumorigenesis. RESULTS: IL-11 was up-regulated significantly in 4 diverse mouse models of gastric pathology as well as in human biopsy specimens adjacent to and within gastric cancer. Removal of IL-11 co-receptor alpha significantly reduced HKbeta-/- mouse fundic hyperplasia and ablated gp130(757F/F) mouse tumorigenesis. Exogenous IL-11 but not IL-6 activated oncogenic signal transducer and activator of transcription-3, and altered expression of novel proliferative and cytoprotective genes RegIII-beta, RegIII-gamma, gremlin-1, clusterin, and growth arrest specific-1 in wild-type gastric mucosa, a gene signature common in gp130(757F/F) and HKbeta-/- tumors as well as nonneoplastic mucosa of gastric cancer patients. One week of chronic IL-11 administration in wild-type mice sustained the gene signature, causing pretumorigenic changes in both antrum and fundus. CONCLUSIONS: Increased gastric IL-11 alters expression of proliferative and cytoprotective genes and promotes pretumorigenic cellular changes.


Subject(s)
Epithelial Cells/physiology , Interleukin-11/genetics , Interleukin-11/metabolism , Stomach Neoplasms/pathology , Stomach Neoplasms/physiopathology , Animals , Biopsy , Cytokine Receptor gp130/genetics , Cytokine Receptor gp130/metabolism , Disease Models, Animal , Epithelial Cells/pathology , Gastric Fundus/pathology , Gastric Fundus/physiology , Gastric Mucosa/pathology , Gastric Mucosa/physiopathology , Gene Expression Regulation, Neoplastic , H(+)-K(+)-Exchanging ATPase/genetics , H(+)-K(+)-Exchanging ATPase/metabolism , Homeostasis/physiology , Humans , Hyperplasia , Interleukin-11/pharmacology , Interleukin-11 Receptor alpha Subunit/metabolism , Interleukin-6/pharmacology , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , Mice, Mutant Strains , Oligonucleotide Array Sequence Analysis , Proto-Oncogene Proteins c-akt/metabolism , Pyloric Antrum/pathology , Pyloric Antrum/physiology , STAT3 Transcription Factor/metabolism
10.
Mol Genet Genomics ; 284(6): 425-35, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20882389

ABSTRACT

Phosphite, an analog of phosphate is used to control oomycete diseases on a wide range of horticultural crops and in native ecosystems. In this study, we investigated morphological and transcriptional changes induced in Phytophthora cinnamomi by phosphite. Cytological observations revealed that phosphite caused hyphal distortions and lysis of cell walls and had an adverse effect on hyphal growth. At the molecular level, the expression levels of 43 transcripts were changed. Many of these encoded proteins involved in cell wall synthesis, or cytoskeleton functioning. The results of both the microscopic and molecular investigations are consistent with phosphite inhibiting the function of the cytoskeleton and cell wall synthesis.


Subject(s)
Phosphites/pharmacology , Phytophthora/drug effects , Phytophthora/genetics , Base Sequence , Cell Wall/drug effects , Cell Wall/metabolism , Cytoskeleton/drug effects , Cytoskeleton/metabolism , DNA Primers/genetics , Gene Expression/drug effects , Gene Expression Profiling , Oligonucleotide Array Sequence Analysis , Phytophthora/growth & development , Phytophthora/metabolism , Plant Diseases/parasitology , Reverse Transcriptase Polymerase Chain Reaction
11.
BMC Med ; 8: 64, 2010 Oct 21.
Article in English | MEDLINE | ID: mdl-20964835

ABSTRACT

BACKGROUND: The commonest histological type of renal cancer, clear cell renal cell carcinoma (cc RCC), is associated with genetic and epigenetic changes in the von Hippel-Lindau (VHL) tumour suppressor. VHL inactivation leads to induction of hypoxia-inducible factors (HIFs) and a hypoxic pattern of gene expression. Differential levels of specific microRNAs (miRNAs) are observed in several tumours when compared to normal tissue. Given the central role of VHL in renal cancer formation, we examined the VHL-dependent regulation of miRNAs in renal cancer. METHODS: VHL-dependent miRNA expression in cc RCC was determined by microarray analysis of renal cell line RCC4 with mutated VHL (RCC4-VHL) and reintroduced wild-type VHL (RCC4 + VHL). Five miRNAs highly upregulated in RCC4 + VHL and five miRNAs highly downregulated in RCC4 + VHL were studied further, in addition to miR-210, which is regulated by the HIF-VHL system. miRNA expression was also measured in 31 cc RCC tumours compared to adjacent normal tissue. RESULTS: A significant increase in miR-210, miR-155 and miR-21 expression was observed in the tumour tissue. miR-210 levels also showed a correlation with a HIF-regulated mRNA, carbonic anhydrase IX (CAIX), and with VHL mutation or promoter methylation. An inverse correlation was observed between miR-210 expression and patient survival, and a putative target of miR-210, iron-sulfur cluster assembly protein (ISCU1/2), shows reciprocal levels of mRNA expression in the tumours. CONCLUSIONS: We have identified VHL-regulated miRNAs and found that for some the regulation is HIF-dependent and for others it is HIF-independent. This pattern of regulation was also seen in renal cancer tissue for several of these miRNAs (miR-210, miR-155, let-7i and members of the miR-17-92 cluster) when compared with normal tissue. miR-210 showed marked increases in expression in renal cancer and levels correlated with patient survival. The inverse correlation between miR-210 levels and ISCU1/2 provides support for the hypothesis that ISCU1/2 is a target of miR-210 and that it may contribute to the anaerobic respiration seen in renal (and other) tumours.See Commentary: http://www.biomedcentral.com/1741-7015/8/65.


Subject(s)
Carcinoma, Renal Cell/genetics , Kidney Neoplasms/genetics , MicroRNAs/metabolism , Von Hippel-Lindau Tumor Suppressor Protein/genetics , Adult , Aged , Aged, 80 and over , Antigens, Neoplasm/metabolism , Basic Helix-Loop-Helix Transcription Factors/metabolism , Carbonic Anhydrase IX , Carbonic Anhydrases/metabolism , Carcinoma, Renal Cell/metabolism , Carcinoma, Renal Cell/mortality , Cell Hypoxia , Cell Line, Tumor , Female , Gene Expression/genetics , Humans , Hypoxia-Inducible Factor 1, alpha Subunit/metabolism , Iron-Sulfur Proteins/genetics , Kaplan-Meier Estimate , Kidney Neoplasms/metabolism , Kidney Neoplasms/mortality , Male , Microarray Analysis , Middle Aged , Polymerase Chain Reaction , Statistics, Nonparametric , Tumor Cells, Cultured
12.
Mol Endocrinol ; 23(2): 265-75, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19074548

ABSTRACT

Endometriosis is a prevalent gynecological disease characterized by growth of endometriotic tissue outside the uterine cavity. MicroRNAs (miRNAs) are naturally occurring posttranscriptional regulatory molecules that potentially play a role in endometriotic lesion development. We assessed miRNA expression by microarray analysis in paired ectopic and eutopic endometrial tissues and identified 14 up-regulated (miR-145, miR-143, miR-99a, miR-99b, miR-126, miR-100, miR-125b, miR-150, miR-125a, miR-223, miR-194, miR-365, miR-29c and miR-1) and eight down-regulated (miR-200a, miR-141, miR-200b, miR-142-3p, miR-424, miR-34c, miR-20a and miR-196b) miRNAs. The differential expression of six miRNAs was confirmed by quantitative RT-PCR. An in silico analysis identified 3851 mRNA transcripts as putative targets of the 22 miRNAs. Of these predicted targets, 673 were also differentially expressed in ectopic vs. eutopic endometrial tissue, as determined by microarray. Functional analysis suggested that the 673 miRNA targets constitute molecular pathways previously associated with endometriosis, including c-Jun, CREB-binding protein, protein kinase B (Akt), and cyclin D1 (CCND1) signaling. These pathways appeared to be regulated both transcriptionally as well as by miRNAs at posttranscriptional level. These data are a rich and novel resource for endometriosis and miRNA research and suggest that the 22 miRNAs and their cognate mRNA target sequences constitute pathways that promote endometriosis. Accordingly, miRNAs are potential therapeutic targets for treating this disease.


Subject(s)
Endometriosis , Gene Expression Regulation , MicroRNAs/metabolism , Signal Transduction/physiology , Endometriosis/genetics , Endometriosis/metabolism , Endometriosis/pathology , Female , Gene Expression Profiling , Humans , JNK Mitogen-Activated Protein Kinases/genetics , JNK Mitogen-Activated Protein Kinases/metabolism , MicroRNAs/genetics , Molecular Sequence Data , Multigene Family , Oligonucleotide Array Sequence Analysis
13.
J Mol Diagn ; 19(5): 711-721, 2017 09.
Article in English | MEDLINE | ID: mdl-28732215

ABSTRACT

Somatic mitochondrial DNA (mtDNA) mutations have been identified in many human cancers, including leukemia. To identify somatic mutations, it is necessary to have a control tissue from the same individual for comparison. When patients with leukemia achieve remission, the remission peripheral blood may be a suitable and easily accessible control tissue, but this approach has not previously been applied to the study of mtDNA mutations. We have developed and validated a next-generation sequencing approach for the identification of leukemia-associated mtDNA mutations in 26 chronic myeloid leukemia patients at diagnosis using either nonhematopoietic or remission blood samples as the control. The entire mt genome was amplified by long-range PCR and sequenced using Illumina technology. Variant caller software was used to detect mtDNA somatic mutations, and an empirically determined threshold of 2% was applied to minimize false-positive results because of sequencing errors. Mutations were called against both nonhematopoietic and remission controls: the overall concordance between the two approaches was 81% (73/90 mutations). Some discordant results were because of the presence of somatic mutations in remission samples, because of either minimal residual disease or nonleukemic hematopoietic clones. This method could be applied to study somatic mtDNA mutations in leukemia patients who achieve minimal residual disease, and in patients with nonhematopoietic cancers who have a matched uninvolved tissue available.


Subject(s)
DNA Mutational Analysis/methods , DNA, Mitochondrial , High-Throughput Nucleotide Sequencing , Leukemia/diagnosis , Leukemia/genetics , Mutation , Alleles , Biomarkers, Tumor , DNA Mutational Analysis/standards , High-Throughput Nucleotide Sequencing/methods , High-Throughput Nucleotide Sequencing/standards , Humans , Leukemia/drug therapy , Polymerase Chain Reaction , Remission Induction , Reproducibility of Results , Sequence Analysis, DNA/methods , Sequence Analysis, DNA/standards
14.
J Alzheimers Dis ; 52(2): 581-608, 2016 03 31.
Article in English | MEDLINE | ID: mdl-27031468

ABSTRACT

Dominant mutations in the PRESENILIN genes PSEN1 and PSEN2 cause familial Alzheimer's disease (fAD) that usually shows onset before 65 years of age. In contrast, genetic variation at the PSEN1 and PSEN2 loci does not appear to contribute to risk for the sporadic, late onset form of the disease (sAD), leading to doubts that these genes play a role in the majority of AD cases. However, a truncated isoform of PSEN2, PS2V, is upregulated in sAD brains and is induced by hypoxia and high cholesterol intake. PS2V can increase γ-secretase activity and suppress the unfolded protein response (UPR), but detailed analysis of its function has been hindered by lack of a suitable, genetically manipulable animal model since mice and rats lack this PRESENILIN isoform. We recently showed that zebrafish possess an isoform, PS1IV, that is cognate to human PS2V. Using an antisense morpholino oligonucleotide, we can block specifically the induction of PS1IV that normally occurs under hypoxia. Here, we exploit this ability to identify gene regulatory networks that are modulated by PS1IV. When PS1IV is absent under hypoxia-like conditions, we observe changes in expression of genes controlling inflammation (particularly sAD-associated IL1B and CCR5), vascular development, the UPR, protein synthesis, calcium homeostasis, catecholamine biosynthesis, TOR signaling, and cell proliferation. Our results imply an important role for PS2V in sAD as a component of a pathological mechanism that includes hypoxia/oxidative stress and support investigation of the role of PS2V in other diseases, including schizophrenia, when these are implicated in the pathology.


Subject(s)
Hypoxia/immunology , Presenilin-1/metabolism , Animals , Disease Models, Animal , Gene Expression Profiling , Gene Regulatory Networks , Hypoxia/genetics , Interleukin-1beta/metabolism , Microarray Analysis , Morpholinos , Oligonucleotides, Antisense , Presenilin-1/antagonists & inhibitors , Presenilin-1/genetics , Protein Isoforms , Real-Time Polymerase Chain Reaction , Receptors, CCR5/metabolism , Zebrafish , Zebrafish Proteins/metabolism
15.
PLoS One ; 10(11): e0141816, 2015.
Article in English | MEDLINE | ID: mdl-26539717

ABSTRACT

Streptococcus pneumoniae (the pneumococcus) continues to account for significant morbidity and mortality worldwide, causing life-threatening diseases such as pneumonia, bacteremia and meningitis, as well as less serious infections such as sinusitis, conjunctivitis and otitis media. Current polysaccharide vaccines are strictly serotype-specific and also drive the emergence of non-vaccine serotype strains. In this study, we used microarray analysis to compare gene expression patterns of either serotype 4 or serotype 6A pneumococci in the nasopharynx and blood of mice, as a model to identify genes involved in invasion of blood in the context of occult bacteremia in humans. In this manner, we identified 26 genes that were significantly up-regulated in the nasopharynx and 36 genes that were significantly up-regulated in the blood that were common to both strains. Gene Ontology classification revealed that transporter and DNA binding (transcription factor) activities constitute the significantly different molecular functional categories for genes up-regulated in the nasopharynx and blood. Targeted mutagenesis of selected genes from both niches and subsequent virulence and pathogenesis studies identified the manganese-dependent superoxide dismutase (SodA) as most likely to be essential for colonization, and the cell wall-associated serine protease (PrtA) as important for invasion of blood. This work extends our previous analyses and suggests that both PrtA and SodA warrant examination in future studies aimed at prevention and/or control of pneumococcal disease.


Subject(s)
Bacteremia/microbiology , Genes, Bacterial/genetics , Pneumococcal Infections/microbiology , Streptococcus pneumoniae/genetics , Animals , Disease Models, Animal , Female , Male , Mice , Nasopharynx/microbiology , Otitis Media/microbiology , Serogroup , Superoxide Dismutase/genetics , Up-Regulation/genetics , Virulence/genetics , Virulence Factors/genetics
16.
J Interferon Cytokine Res ; 35(5): 392-400, 2015 May.
Article in English | MEDLINE | ID: mdl-25588104

ABSTRACT

The pathogenesis of nonalcoholic steatohepatitis is primarily an immune-driven disease and a known factor associated with treatment failure of chronic hepatitis C with interferon (IFN) and ribavirin. We studied the hepatocyte response in a model of steatosis at the transcriptome level and the antiviral action of IFN against hepatitis C virus (HCV) in this setting. In this study, we have shown that lipid loading (oleic acid and palmitic acid, OA:PA) of Huh-7 cells leads to increased expression of classical interferon-stimulated genes (ISGs) and NF-κß-dependent pro-inflammatory genes. A selective blocker of Toll-like receptor (TLR)2 signaling suppressed NF-κß promoter activity by OA:PA, suggesting that free fatty acids (FFAs) act as a TLR2 pathogen-associated molecular pattern. Furthermore, in the presence of OA:PA, IFN stimulation and HCV infection (Jc1) increased ISG expression. Somewhat counterintuitive to the increase in ISGs, the anti-HCV activity of IFN was attenuated in the presence of OA:PA. Interestingly, the combination of OA:PA, HCV, and IFN-α stimulation resulted in a significant increase in CXCL8 protein production, a cytokine known to have anti-IFN modulating activity. Thus, in an in vitro model of steatosis, the FFAs OA and PA drive an NF-κß-dependent inflammatory and ISG gene expression profile via TLR2 activation. Furthermore, FFA synergistically increases IFN-driven gene expression that may account for HCV treatment failure in vivo.


Subject(s)
Fatty Acids/metabolism , Hepacivirus/physiology , Hepatitis C, Chronic/genetics , Hepatitis C, Chronic/metabolism , Interferons/metabolism , Transcriptome , Cell Line , Cluster Analysis , Drug Synergism , Fatty Acids/pharmacology , Fatty Liver/etiology , Fatty Liver/metabolism , Gene Expression Profiling , Gene Expression Regulation/drug effects , Hepacivirus/drug effects , Humans , Interferons/pharmacology , NF-kappa B/metabolism , Oleic Acid/pharmacology , Palmitic Acid/pharmacology , Toll-Like Receptor 2/metabolism , Virus Replication/drug effects
17.
World J Gastroenterol ; 20(40): 14904-12, 2014 Oct 28.
Article in English | MEDLINE | ID: mdl-25356050

ABSTRACT

AIM: To investigate expression of microRNA (miRNA) and potential targets in chemotherapy resistant esophageal cancer cell lines. METHODS: An in-vitro model of acquired chemotherapy resistance in esophageal adeno- (EAC) and squamous cell carcinoma (ESCC) cells was used, and microRNA expression profiles for cisplatin or 5-fluorouracil (5-FU) resistant variants vs chemotherapy sensitive controls were compared using microarray and quantitative real-time polymerase chain reaction (PCR). The expression of chemotherapy-relevant genes potentially targeted by the dysregulated microRNAs in the chemotherapy resistant variants was also evaluated. RESULTS: Chemotherapy resistant sublines were found to have specific miRNA signatures, and these miRNA signatures were different for the cisplatin vs 5-FU resistant cells from the same tumor cell line, and also for EAC vs ESCC cells with resistance to the same specific chemotherapy agent. Amongst others, miR-27b-3p, miR-193b-3p, miR-192-5p, miR-378 a-3p, miR-125a-5p and miR-18a-3p were dysregulated, consistent with negative posttranscriptional control of KRAS, TYMS, ABCC3, CBL-B and ERBB2 expression via these miRNAs. CONCLUSION: The current study supports the hypothesis that microRNA expression has an impact on chemotherapy resistance in esophageal cancer.


Subject(s)
Adenocarcinoma/genetics , Biomarkers, Tumor/genetics , Carcinoma, Squamous Cell/genetics , Drug Resistance, Neoplasm/genetics , Esophageal Neoplasms/genetics , Gene Expression Profiling , MicroRNAs/genetics , Adenocarcinoma/metabolism , Adenocarcinoma/pathology , Antineoplastic Agents/pharmacology , Biomarkers, Tumor/metabolism , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Cell Survival/drug effects , Cisplatin/pharmacology , Esophageal Neoplasms/metabolism , Esophageal Neoplasms/pathology , Esophageal Squamous Cell Carcinoma , Fluorouracil/pharmacology , Gene Expression Profiling/methods , Gene Expression Regulation, Neoplastic , Humans , MicroRNAs/metabolism , Oligonucleotide Array Sequence Analysis , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction
18.
Nat Commun ; 4: 1764, 2013.
Article in English | MEDLINE | ID: mdl-23612305

ABSTRACT

Haplogroup H dominates present-day Western European mitochondrial DNA variability (>40%), yet was less common (~19%) among Early Neolithic farmers (~5450 BC) and virtually absent in Mesolithic hunter-gatherers. Here we investigate this major component of the maternal population history of modern Europeans and sequence 39 complete haplogroup H mitochondrial genomes from ancient human remains. We then compare this 'real-time' genetic data with cultural changes taking place between the Early Neolithic (~5450 BC) and Bronze Age (~2200 BC) in Central Europe. Our results reveal that the current diversity and distribution of haplogroup H were largely established by the Mid Neolithic (~4000 BC), but with substantial genetic contributions from subsequent pan-European cultures such as the Bell Beakers expanding out of Iberia in the Late Neolithic (~2800 BC). Dated haplogroup H genomes allow us to reconstruct the recent evolutionary history of haplogroup H and reveal a mutation rate 45% higher than current estimates for human mitochondria.


Subject(s)
Genome, Human/genetics , Genome, Mitochondrial/genetics , Haplotypes/genetics , Phylogeny , White People/genetics , Base Sequence , Demography , Evolution, Molecular , Genetics, Population , Humans , Molecular Sequence Data , Principal Component Analysis , Sequence Analysis, DNA , Time Factors
19.
J Clin Invest ; 122(6): 2208-20, 2012 Jun.
Article in English | MEDLINE | ID: mdl-22622042

ABSTRACT

Streptococcus pneumoniae is the most common cause of severe bacterial meningitis in children, the elderly, and immunocompromised individuals. To identify virulence factors preferentially expressed during meningitis, we conducted niche-specific genome-wide in vivo transcriptomic analysis after intranasal infection of mice with serotype 4 or 6A pneumococci. The expression of 34 bacterial genes was substantially altered in brain tissue of mice infected with either of the 2 strains. Ten upregulated genes were common to both strains, 7 of which were evaluated for their role in the development of meningitis. One previously uncharacterized protein, α-glycerophosphate oxidase (GlpO), was cytotoxic for human brain microvascular endothelial cells (HBMECs) via generation of H(2)O(2). A glpO deletion mutant was defective in adherence to HBMECs in vitro as well as in progression from the blood to the brain in vivo. Mutant bacteria also induced markedly reduced meningeal inflammation and brain pathology compared with wild type, despite similar levels of bacteremia. Immunization of mice with GlpO protected against invasive pneumococcal disease and provided additive protection when formulated with pneumolysin toxoid. Our results provide the basis of a strategy that can be adapted to identify genes that contribute to the development of meningitis caused by other pathogens.


Subject(s)
Antigens, Bacterial/biosynthesis , Glycerolphosphate Dehydrogenase/biosynthesis , Meningitis, Pneumococcal/enzymology , Pneumococcal Vaccines/metabolism , Streptococcus pneumoniae/enzymology , Animals , Antigens, Bacterial/genetics , Antigens, Bacterial/immunology , Bacterial Proteins/immunology , Bacterial Proteins/pharmacology , Cells, Cultured , Female , Gene Expression Regulation, Bacterial/immunology , Gene Expression Regulation, Enzymologic/immunology , Glycerolphosphate Dehydrogenase/genetics , Glycerolphosphate Dehydrogenase/immunology , Humans , Meningitis, Pneumococcal/genetics , Meningitis, Pneumococcal/immunology , Meningitis, Pneumococcal/prevention & control , Mice , Mutation , Pneumococcal Vaccines/immunology , Streptococcus pneumoniae/genetics , Streptococcus pneumoniae/immunology , Streptolysins/immunology , Streptolysins/pharmacology , Toxoids/immunology , Toxoids/pharmacology
20.
Oncol Rep ; 26(4): 1011-7, 2011 Oct.
Article in English | MEDLINE | ID: mdl-21743970

ABSTRACT

Neoadjuvant chemotherapy is often used in the treatment of advanced esophageal cancer. In this study, we determined the impact of chemotherapy on microRNA (miRNA) expression in esophageal cancer cells, and whether identified changes might have biological relevance. Two esophageal carcinoma cell lines (one adenocarcinoma and one squamous cell carcinoma) were treated with cisplatin or 5-fluorouracil for 24 or 72 h. RNA was extracted from cells following 24-h treatment, and used for microarray studies. Promising miRNA candidates were selected for RT-PCR validation. Target prediction using TargetScan, combined with bioinformatic analysis (Ingenuity Pathway Analysis, IPA), was performed to evaluate the implications of the altered miRNA expression. Thirteen miRNAs (miR-199a-5p, miR-302f, miR-320a, miR-342-3p, miR-425, miR-455-3p, miR-486-3p, miR-519c-5p, miR-548d-5p, miR-617, miR-758, miR-766, miR-1286) were deregulated after 24- and/or 72-h treatment in both cell lines, and most miRNAs presented similar expression changes after short- or long-term exposure. IPA revealed that the major networks which incorporate the predicted targets, include functions such as 'Cell death', 'Cell cycle', 'Cellular growth and proliferation', 'DNA replication, recombination, and repair' and 'Drug metabolism'. Cisplatin or 5-fluorouracil alter miRNA expression in esophageal cancer cells. IPA suggests that these miRNAs may target molecular pathways involved in cell survival after chemotherapy.


Subject(s)
Antineoplastic Agents/pharmacology , Cisplatin/pharmacology , Esophageal Neoplasms/drug therapy , Esophageal Neoplasms/genetics , Fluorouracil/pharmacology , MicroRNAs/biosynthesis , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/metabolism , Carcinoma, Squamous Cell/pathology , Cell Line, Tumor , Esophageal Neoplasms/metabolism , Esophageal Neoplasms/pathology , Gene Expression Regulation, Neoplastic , Humans , MicroRNAs/genetics , Prognosis , RNA, Messenger/biosynthesis , RNA, Messenger/genetics
SELECTION OF CITATIONS
SEARCH DETAIL